{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:35:49Z","timestamp":1784140549216,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.eplepsyres.2017.11.013","type":"journal-article","created":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T17:35:39Z","timestamp":1512149739000},"page":"80-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Vitamin D deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy"],"prefix":"10.1016","volume":"139","author":[{"given":"Teodoro","family":"Dur\u00e1-Trav\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidel","family":"Gallinas-Victoriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Malumbres-Chac\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Moreno-G\u00f3nzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Aguilera-Albesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eugenia","family":"Yoldi-Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.metabol.2007.08.023","article-title":"Hypovitaminosis D in obese children and adolescents: relationship with adiposity insulin sensitivity, ethnicity, and season","volume":"57","author":"Alemzadeh","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3349\/ymj.2014.55.2.417","article-title":"Vitamin D levels in children and adolescents with antiepileptic drug treatment","volume":"55","author":"Baek","year":"2014","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0015","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0883073812443005","article-title":"Antiepileptic drugs and bone metabolism in children: data from 128 patients","volume":"28","author":"Borusiak","year":"2013","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.pediatrneurol.2008.07.001","article-title":"Evaluation of bone turnover in epileptic children using oxcarbazepine","volume":"39","author":"Cansu","year":"2008","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0030","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/14737175.2014.905742","article-title":"Epilepsy treatment by sacrificing vitamin D","volume":"14","author":"Cebeci","year":"2014","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0035","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmj.2.5913.258","article-title":"Anticonvulsant action of vitamin D in epileptic patients? A controlled pilot study","volume":"2","author":"Christiansen","year":"1974","journal-title":"Br. Med. J."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0040","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1038\/nutd.2016.50","article-title":"Prevalence of hypovitaminosis D and associated factors in obese Spanish children","volume":"7","author":"Dur\u00e1-Trav\u00e9","year":"2017","journal-title":"Nutr. Diab."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.eplepsyres.2013.08.012","article-title":"The effect of levetiracetam on rat bone mass, structure and metabolism","volume":"107","author":"Fekete","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0050","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/0883073812472256","article-title":"Vitamin D. deficiency among children with epilepsy in South Queensland","volume":"29","author":"Fong","year":"2014","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1517\/14740338.6.3.267","article-title":"Adverse effects of antiepileptic drugs on bone mineral density in children","volume":"6","author":"Gissel","year":"2007","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0060","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.33588\/rn.3711.2003423","article-title":"Effectiveness and tolerability of levetiracetam in 43 children and adolescents with epilepsy","volume":"37","author":"Herranz","year":"2003","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0065","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0070","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jc.2011-2601","article-title":"Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited","volume":"97","author":"Holick","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.brainresbull.2005.06.022","article-title":"Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice","volume":"67","author":"Kalueff","year":"2005","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0080","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/MPG.0000000000000274","article-title":"Seasonal vitamin D status of healthy schoolchildren and predictors of low vitamin D status","volume":"58","author":"Karag\u00fczel","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0085","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1507\/endocrj.EJ12-0143","article-title":"Association of vitamin D-related gene polymorphisms with manifestation of vitamin D deficiency in children","volume":"59","author":"Kitanaka","year":"2012","journal-title":"Endocr. J."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eplepsyres.2012.09.002","article-title":"Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy","volume":"104","author":"Koo","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0095","doi-asserted-by":"crossref","first-page":"198","DOI":"10.6065\/apem.2015.20.4.198","article-title":"Risk factors of vitamin D deficiency in children with epilepsy taking anticonvulsants at initial and during follow-up","volume":"20","author":"Lee","year":"2015","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0100","first-page":"489","article-title":"Levetiracetam: a review of its use in epilepsy","volume":"71","author":"Lyseng-Williamson","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1759720X11410769","article-title":"Antiepileptics and bone health","volume":"3","author":"Meier","year":"2011","journal-title":"Ther. Adv. Musculoskel. Dis."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0110","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pediatrneurol.2010.05.013","article-title":"Effect of carbamazepine therapy on vitamin D and parathormone in epileptic children","volume":"43","author":"Misra","year":"2010","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0115","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00431-008-0672-7","article-title":"Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy","volume":"167","author":"Nettekoven","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0120","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2310\/7010.2006.00050","article-title":"Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study","volume":"21","author":"Nicolaidou","year":"2006","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0125","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1528-1167.2007.01176.x","article-title":"Levetiracetam, phenytoin, and valproate act differently on rat bone mass structure, and metabolism","volume":"48","author":"Nissen-Meyer","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/PRM-140287","article-title":"Vitamin D, bone health, and other health benefits in pediatric patients","volume":"7","author":"Palermo","year":"2014","journal-title":"J. Pediatr. Rehabil. Med."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0135","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/epi.13474","article-title":"The antiepileptic medications carbamazepine and phenytoin inhibit native sodium currents in murine osteoblasts","volume":"57","author":"Petty","year":"2016","journal-title":"Epilepsia"},{"issue":"144","key":"10.1016\/j.eplepsyres.2017.11.013_bib0140","first-page":"w13996","article-title":"Vitamin D status among children and adolescents on anticonvulsant drugs in southern Switzerland","volume":"13","author":"Ramelli","year":"2014","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1469-8749.2009.03402.x","article-title":"Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children","volume":"52","author":"Rauchenzauner","year":"2010","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0150","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archpedi.162.6.513","article-title":"Hypovitaminosis d among healthy children in the United States a review of the current evidence","volume":"162","author":"Rovner","year":"2008","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0155","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.yebeh.2015.06.025","article-title":"The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine","volume":"51","author":"Serin","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pediatrneurol.2009.12.005","article-title":"Vitamin D and bone health among children with epilepsy","volume":"42","author":"Shellhaas","year":"2010","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0165","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.eplepsyres.2014.06.008","article-title":"Low Vitamin D levels are common in patients with epilepsy","volume":"108","author":"Teagarden","year":"2014","journal-title":"Epilepsy Res."},{"issue":"141","key":"10.1016\/j.eplepsyres.2017.11.013_bib0170","first-page":"150","article-title":"Effects of antiepileptic drugs on bone health and growth potential on children with epilepsy","volume":"17","author":"Vestergaard","year":"2015","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0175","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00431-013-2119-z","article-title":"Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study","volume":"172","author":"Vierucci","year":"2013","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0180","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ajcn\/86.1.150","article-title":"Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents","volume":"86","author":"Weng","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.eplepsyres.2017.11.013_bib0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1734-1140(13)71003-X","article-title":"Vitamin D and the central nervous system","volume":"65","author":"Wrzosek","year":"2013","journal-title":"Pharmacol. Rep."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117304151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121117304151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T23:11:23Z","timestamp":1751065883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121117304151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":37,"alternative-id":["S0920121117304151"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.11.013","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}